MedTrace Logo

NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification

NCT06141395 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-03-29

No results posted yet for this study

Summary

Rapid detection of microorganisms is a promising approach towards early administration of appropriate antibiotics for sepsis. This study aims to investigate the potential of a new NGS platform for the rapid diagnosis of circulating bacteria in blood.

Conditions

  • Pneumonia
  • Acute Pyelonephritis
  • Bacteremia
  • Biliary Tract Infection

Interventions

DIAGNOSTIC_TEST

NGS-based assay for bacterial identification

A total volume of 26ml of whole blood will be sampled from each enrolled patient for three consecutive days. This will be used for Standard-of-Care (SoC) culture and Next Generation Sequencing (NGS), for identification of circulating microorganisms.

Sponsors & Collaborators

  • The BioArte

    collaborator UNKNOWN

  • Hellenic Institute for the Study of Sepsis

    lead OTHER

Principal Investigators

  • Evangelos Giamarellos-Bourboulis, MD,PhD · Hellenic Institute for the Study of Sepsis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-16
Primary Completion
2024-03-14
Completion
2024-03-14

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06141395 on ClinicalTrials.gov